Denali Therapeutics Inc (DNLI)
Income Before Tax
-$127.55M
Quarterly · Period ending: · USD
DNLI Income Before Tax
Latest reported-$127.55Mperiod ending
Latest reported-$127.55Mperiod ending
DNLI Quarterly Pre-Tax Income (-$18.34M → -$127.55M)
Quarterly income before tax
High-resolution chart · PNG
DNLI income before tax history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Before Tax (USD) |
|---|---|
| -127,553,000 | |
| -128,447,000 | |
| -128,447,000 | |
| -126,902,000 | |
| -124,119,000 | |
| -132,970,000 | |
| -114,685,000 | |
| -107,192,000 | |
| -99,026,000 | |
| -101,802,000 | |
| -119,443,000 | |
| -99,353,000 | |
| 183,383,000 | |
| -109,781,000 | |
| -98,684,000 | |
| -103,299,000 | |
| -58,767,000 | |
| -65,220,000 | |
| -75,836,000 | |
| -84,588,000 | |
| -60,691,000 | |
| -70,041,000 | |
| 245,708,000 | |
| -58,172,000 | |
| -58,679,000 | |
| -56,898,000 | |
| -53,950,000 | |
| -46,373,000 | |
| -58,650,000 | |
| -38,992,000 | |
| 77,533,000 | |
| -35,371,000 | |
| -54,724,000 | |
| -23,678,000 | |
| -22,887,000 | |
| -21,844,000 | |
| -22,134,000 | |
| -21,320,000 | |
| -19,354,000 | |
| -30,611,000 | |
| -18,343,500 | |
| -18,343,500 |